Literature DB >> 18989120

Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas.

Elizabeth R Gerstner1, A Gregory Sorensen, Rakesh K Jain, Tracy T Batchelor.   

Abstract

PURPOSE OF REVIEW: This review will summarize new neuroimaging techniques, particularly MRI and PET imaging, that can be used to assess brain tumor growth and angiogenesis. RECENT
FINDINGS: Glioma tumor vasculature is abnormal, and advances in MRI now permit visualization of the hemodynamic properties of gliomas including cerebral blood volume and blood flow, vascular permeability, and blood vessel diameter. New radiolabeled PET tracers have allowed more specific interrogation of glioma physiology such as hypoxia assessment or tumor proliferation rate. These two techniques are complementary and will likely yield important information on tumor response to therapy, particularly in the setting of antiangiogenic agents, which confound the interpretation of standard contrast-enhanced MRI scans.
SUMMARY: These techniques may allow development of patient-specific therapy to improve outcome in patients with gliomas.

Entities:  

Mesh:

Year:  2008        PMID: 18989120     DOI: 10.1097/WCO.0b013e328318402a

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  26 in total

1.  A fully automated method for quantitative cerebral hemodynamic analysis using DSC-MRI.

Authors:  Atle Bjørnerud; Kyrre E Emblem
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-20       Impact factor: 6.200

2.  Modeling the growth dynamics of glioblastoma using magnetic resonance imaging.

Authors:  Chaitra Badve; Andrew E Sloan
Journal:  Neuro Oncol       Date:  2015-07-12       Impact factor: 12.300

3.  Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.

Authors:  Andrés Server; Tone E Døli Orheim; Bjørn A Graff; Roger Josefsen; Theresa Kumar; Per H Nakstad
Journal:  Neuroradiology       Date:  2010-07-13       Impact factor: 2.804

Review 4.  Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma.

Authors:  Erwin G Van Meir; Costas G Hadjipanayis; Andrew D Norden; Hui-Kuo Shu; Patrick Y Wen; Jeffrey J Olson
Journal:  CA Cancer J Clin       Date:  2010 May-Jun       Impact factor: 508.702

5.  Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival.

Authors:  Valeria Cuccarini; A Erbetta; M Farinotti; L Cuppini; F Ghielmetti; B Pollo; F Di Meco; M Grisoli; G Filippini; G Finocchiaro; M G Bruzzone; M Eoli
Journal:  J Neurooncol       Date:  2016-01       Impact factor: 4.130

6.  Novel membrane-permeable contrast agent for brain tumor detection by MRI.

Authors:  Mohanraja Kumar; Zdravka Medarova; Pamela Pantazopoulos; Guangping Dai; Anna Moore
Journal:  Magn Reson Med       Date:  2010-03       Impact factor: 4.668

Review 7.  [Pseudoprogression or pseudoresponse: a challenge for the diagnostic imaging in Glioblastoma multiforme].

Authors:  Franz Payer
Journal:  Wien Med Wochenschr       Date:  2011-01

8.  MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas.

Authors:  Mukund Seshadri; Michael J Ciesielski
Journal:  J Cereb Blood Flow Metab       Date:  2009-05-20       Impact factor: 6.200

Review 9.  Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety.

Authors:  Marianela Candolfi; Kurt M Kroeger; A K M G Muhammad; Kader Yagiz; Catherine Farrokhi; Robert N Pechnick; Pedro R Lowenstein; Maria G Castro
Journal:  Curr Gene Ther       Date:  2009-10       Impact factor: 4.391

Review 10.  Targeting angiogenesis: progress with anti-VEGF treatment with large molecules.

Authors:  Axel Grothey; Evanthia Galanis
Journal:  Nat Rev Clin Oncol       Date:  2009-07-28       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.